Publikationen 1991-2000
Publikationen 1991 - 2000
2000
41. Hug J, Nagel E, Bornstedt A, Schnackenburg B, Oswald H, Fleck E. Coronary Arterial Stents Safety and Artifacts during MR Imaging Radiology. 2000;216:781-7 (read only).
40. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance Circulation. 2000;101:1379-83.
39. Al-Saadi N, Nagel E, Gross M, Schnackenburg B, Paetsch I, Klein C, Fleck E. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2000;36:1557-64.
38. Nagel E, al-Saadi N, Fleck E. Cardiovascular magnetic resonance: myocardial perfusion. Herz. 2000;25:409-16.
37. Nagel E, Stuber M, Burkhard B, Fischer SE, Scheidegger MB, Boesiger P, Hess OM. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur Heart J. 2000;21:582-9.
36. Nagel E, Stuber M, Lakatos M, Scheidegger MB, Boesiger P, Hess OM. Cardiac rotation and relaxation after anterolateral myocardial infarction. Coron Artery Dis. 2000;11:261-7.
35. Klein C, Nagel E, Schnackenburg B, Bornstedt A, Schalla S, Hoffmann V, Lehning A, Fleck E. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. Magma. 2000;11:65-7.
34. Botnar R, Nagel E, Scheidegger MB, Pedersen EM, Hess O, Boesiger P. Assessment of prosthetic aortic valve performance by magnetic resonance velocity imaging. Magma. 2000;10:18-26.
33. Nagel E, Schneider U, Schalla S, Ibrahim T, Schnackenburg B, Bornstedt A, Klein C, Lehmkuhl H, Fleck E. Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson. 2000;2:7-14.
32. Nagel E. New strategies for cardiovascular imaging - MRI. Circulation Frontier 2000: 3:12-18
31. Nagel E, Fleck E. Magnetresonanztherapie zur Herzdiagnostik. Humboldt Spektrum 2000; 45:23-30
30. Al-Saadi N, Nagel E, Gross M, Schnackenburg B, Paetsch I, Klein C, Fleck E. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. Journal of the American College of Cardiology. 2000; 36:1557-1564.
1999
40. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance Circulation. 2000;101:1379-83.
39. Al-Saadi N, Nagel E, Gross M, Schnackenburg B, Paetsch I, Klein C, Fleck E. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2000;36:1557-64.
38. Nagel E, al-Saadi N, Fleck E. Cardiovascular magnetic resonance: myocardial perfusion. Herz. 2000;25:409-16.
37. Nagel E, Stuber M, Burkhard B, Fischer SE, Scheidegger MB, Boesiger P, Hess OM. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur Heart J. 2000;21:582-9.
36. Nagel E, Stuber M, Lakatos M, Scheidegger MB, Boesiger P, Hess OM. Cardiac rotation and relaxation after anterolateral myocardial infarction. Coron Artery Dis. 2000;11:261-7.
35. Klein C, Nagel E, Schnackenburg B, Bornstedt A, Schalla S, Hoffmann V, Lehning A, Fleck E. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. Magma. 2000;11:65-7.
34. Botnar R, Nagel E, Scheidegger MB, Pedersen EM, Hess O, Boesiger P. Assessment of prosthetic aortic valve performance by magnetic resonance velocity imaging. Magma. 2000;10:18-26.
33. Nagel E, Schneider U, Schalla S, Ibrahim T, Schnackenburg B, Bornstedt A, Klein C, Lehmkuhl H, Fleck E. Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson. 2000;2:7-14.
32. Nagel E. New strategies for cardiovascular imaging - MRI. Circulation Frontier 2000: 3:12-18
31. Nagel E, Fleck E. Magnetresonanztherapie zur Herzdiagnostik. Humboldt Spektrum 2000; 45:23-30
30. Al-Saadi N, Nagel E, Gross M, Schnackenburg B, Paetsch I, Klein C, Fleck E. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. Journal of the American College of Cardiology. 2000; 36:1557-1564.
1999
29. Stuber M, Scheidegger MB, Fischer SE, Nagel E, Steinemann F, Hess OM, Boesiger P. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation. 1999;100:361-8.
28. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E. Noninvasive Diagnosis of Ischemia induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI Circulation. 1999;99:763-70.
27. Nagel E, Lehmkuhl HB, Klein C, Schneider U, Frantz E, Ellmer A, Bocksch W, Dreysse S, Fleck E. [Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the noninvasive detection of myocardial ischemia]. Z Kardiol. 1999;88:622-30.
26. Nagel E, Bornstedt A, Schnackenburg B, Hug J, Oswald H, Fleck E. Optimization of realtime adaptive navigator correction for 3D magnetic resonance coronary angiography. Magn Reson Med. 1999;42:408-11.
25. Nagel E, Bornstedt A, Hug J, Schnackenburg B, Wellnhofer E, Fleck E. Noninvasive determination of coronary blood flow velocity with magnetic resonance imaging: comparison of breath-hold and navigator techniques with intravascular ultrasound. Magn Reson Med. 1999;41:544-9.
24. Nagel E, Fleck E. Functional MRI in ischemic heart disease based on detection of contraction abnormalities. J Magn Reson Imaging. 1999;10:411-7.
23. Nagel E, Fleck E. Cardiovascular MRI in non-invasive diagnosis of ischemia. Medica Mundi 1999: 43; 2-10
22. Nagel E. Dobutamine stress MRI in the assessment of cardiac wall motion. Medica Mundi 1999, 43;31-38
28. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E. Noninvasive Diagnosis of Ischemia induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI Circulation. 1999;99:763-70.
27. Nagel E, Lehmkuhl HB, Klein C, Schneider U, Frantz E, Ellmer A, Bocksch W, Dreysse S, Fleck E. [Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the noninvasive detection of myocardial ischemia]. Z Kardiol. 1999;88:622-30.
26. Nagel E, Bornstedt A, Schnackenburg B, Hug J, Oswald H, Fleck E. Optimization of realtime adaptive navigator correction for 3D magnetic resonance coronary angiography. Magn Reson Med. 1999;42:408-11.
25. Nagel E, Bornstedt A, Hug J, Schnackenburg B, Wellnhofer E, Fleck E. Noninvasive determination of coronary blood flow velocity with magnetic resonance imaging: comparison of breath-hold and navigator techniques with intravascular ultrasound. Magn Reson Med. 1999;41:544-9.
24. Nagel E, Fleck E. Functional MRI in ischemic heart disease based on detection of contraction abnormalities. J Magn Reson Imaging. 1999;10:411-7.
23. Nagel E, Fleck E. Cardiovascular MRI in non-invasive diagnosis of ischemia. Medica Mundi 1999: 43; 2-10
22. Nagel E. Dobutamine stress MRI in the assessment of cardiac wall motion. Medica Mundi 1999, 43;31-38
1998
21. Nagel E, Underwood R, Penell D, Sechtem UP, Neubauer S, Wickline S, Hess OM, Schwaiger M, Fleck E. [Recent developments in non-invasive heart imaging. Critical evaluation of the use of cardiac magnetic resonance tomography--results of an interdisciplinary workshop]. Dtsch Med Wochenschr. 1998;123:1018-21.
20. Stuber M, Nagel E, Fischer SE, Spiegel MA, Scheidegger MB, Boesiger P. Quantification of the local heartwall motion by magnetic resonance myocardial tagging. Comput Med Imaging Graph. 1998;22:217-28.
19.1. Nagel E, Underwood R, Pennell D, Sechtem UP, Neubauers S, Wickline S, Hess OM, Schwaiger M, Fleck E. New developments in non-invasive cardiac imaging: critical assessment of the clinical role of cardiac magnetic resonance imaging. Eur Heart J. 1998;19:1286-93.
19. Nagel E, Hug J, Bunger S, Bornstedt A, Schnackenburg B, Wellnhofer E, Klein C, Thouet T, Schalla S, Fleck E. Coronary flow measurements for evaluation of patients after stent implantation. Magma. 1998;6:184-5.
18. Nagel E, Stuber M, Fleck E, Boesiger P, Hess OM. Myocardial tagging for the analysis left ventricular function. Magma. 1998;6:91-3.
1997
17. Lins M, Zurborn KH, Dau O, Nagel E, Muurling S, Herrmann G, Simon R. Coagulation activation in patients undergoing directional coronary atherectomy. Thromb Res. 1997;86:433-41
16. Matter C, Mandinov L, Kaufmann P, Nagel E, Boesiger P, Hess OM. [Function of the residual myocardium after infarct and prognostic significance]. Z Kardiol. 1997;86:684-90.
1996
15. Matter C, Nagel E, Stuber M, Boesiger P, Hess OM. Assessment of systolic and diastolic LV function by MR myocardial tagging. Basic Res Cardiol. 1996;91 Suppl 2:23-8.
14. Nagel E, Stuber M, Matter C, Lakatos M, Boesiger P, Hess O. Rotational and translational motion after myocardial infarction. J Cardiovasc Pharmacol. 1996;28:31-35.
13. Nagel E, Stuber M, Hess OM. Importance of the right ventricle in valvular heart disease. Eur Heart 1. 1996;17:829-36.
20. Stuber M, Nagel E, Fischer SE, Spiegel MA, Scheidegger MB, Boesiger P. Quantification of the local heartwall motion by magnetic resonance myocardial tagging. Comput Med Imaging Graph. 1998;22:217-28.
19.1. Nagel E, Underwood R, Pennell D, Sechtem UP, Neubauers S, Wickline S, Hess OM, Schwaiger M, Fleck E. New developments in non-invasive cardiac imaging: critical assessment of the clinical role of cardiac magnetic resonance imaging. Eur Heart J. 1998;19:1286-93.
19. Nagel E, Hug J, Bunger S, Bornstedt A, Schnackenburg B, Wellnhofer E, Klein C, Thouet T, Schalla S, Fleck E. Coronary flow measurements for evaluation of patients after stent implantation. Magma. 1998;6:184-5.
18. Nagel E, Stuber M, Fleck E, Boesiger P, Hess OM. Myocardial tagging for the analysis left ventricular function. Magma. 1998;6:91-3.
1997
17. Lins M, Zurborn KH, Dau O, Nagel E, Muurling S, Herrmann G, Simon R. Coagulation activation in patients undergoing directional coronary atherectomy. Thromb Res. 1997;86:433-41
16. Matter C, Mandinov L, Kaufmann P, Nagel E, Boesiger P, Hess OM. [Function of the residual myocardium after infarct and prognostic significance]. Z Kardiol. 1997;86:684-90.
1996
15. Matter C, Nagel E, Stuber M, Boesiger P, Hess OM. Assessment of systolic and diastolic LV function by MR myocardial tagging. Basic Res Cardiol. 1996;91 Suppl 2:23-8.
14. Nagel E, Stuber M, Matter C, Lakatos M, Boesiger P, Hess O. Rotational and translational motion after myocardial infarction. J Cardiovasc Pharmacol. 1996;28:31-35.
13. Nagel E, Stuber M, Hess OM. Importance of the right ventricle in valvular heart disease. Eur Heart 1. 1996;17:829-36.
1994
12. Muurling SI, Lins M, Nagel E, Alexander H, Herrmann G, Simon R. [Directional coronary atherectomy: effect of vessel size on primary results and long-term results]. Z Kardiol. 1994;83:727-35.
1991
1991
11. Nagel E, Jungehulsing M, Smolarz K, Klaer R, Sechtem U, Schicha H, Hilger HH. [Diagnosis and classification of tricuspid valve insufficiency with dynamic magnetic resonance tomography: comparison with right ventricular angiography]. Z Kardiol. 1991;80:561-8.
Wert
Kontakt zu uns
In den sozialen Netzwerken erfahren Sie
regelmäßig mehr über unser Unternehmen.
regelmäßig mehr über unser Unternehmen.
Partnerseiten
